companydata.dkcompanydata.dk

ORIFARM SUPPLY A/S: Financial statements 2015

CVR: 17153684

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

ORIFARM SUPPLY A/S (CVR 17153684) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 5,003,362,000 and a net result of DKK 13,315,000 compared with DKK 9,557,000 the year before. That is a decrease of 3.4% compared with the year before. The profit margin was 0.3%. Equity in the 2015 report amounted to DKK 203,236,000. The solvency ratio was 20.3%.

Revenue
DKK 5,003,362,000
Gross Profit
DKK 133,755,000
Profit/Loss
DKK 13,315,000
Equity
DKK 203,236,000
Total Assets
DKK 999,591,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20155B133.8M13.3M203.2M-
20145.2B114.7M9.6M68.3M-
20133.4B87.3M-24.4M58.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ORIFARM SUPPLY A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

ORIFARM SUPPLY A/S: The 2014 annual report is outMay 29, 2015

ORIFARM SUPPLY A/S has published its annual report for 2014. Revenue came to DKK 5,178,537,000, and the net result was DKK 9,557,000.

About ORIFARM SUPPLY A/S

ORIFARM SUPPLY A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MEDIPACK A/S and SBH2 ApS. The management consists of Mads Fink Eriksen. The board consists of Ole Michael Friis (chair), Birgitte Bøgh-Sørensen, Hans Carl Bøgh-Sørensen and Nicki Lund Kristensen. The company is owned by MEDIPACK HOLDING A/S. The company has 188 employees (2026). In 2025, the company reported revenue of DKK 11,714,817,000 and a net result of DKK 253,440,000 compared with DKK 269,398,000 the year before. Equity in the 2025 report amounted to DKK 1,337,548,000.

Source: annual report 2025, Danish Business Authority